…gical malignancies but limited clinical benefit in treatment of solid cancer. Tumour antigen heterogeneity and antigen escape are obstacles …
Ovarian cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning Ovarian cancer
65 articles · page 3 of 6… without a pathway-specific activator. In the EVPT assay, fresh ovarian cancer ascites samples were processed to isolate tumor clusters, embed…
…en-expression in healthy tissues. Particularly immunotherapy in ovarian cancer (OC) has had limited success due to the absence of ‘clean’ TAAs…
…ged CPLN and their relevance in managing patients with advanced ovarian cancer and found it as an adverse prognostic factor. Transdiaphragmati…
…apy has been tested in other solid tumour malignancies, such as renal cell carcinoma (29% ORR in 7 patients),49 non-small cell lung cancer (23% ORR …
…Ovarian cancer (OC) remains one of the deadliest gynecologic malignancies, and…
…Ovarian cancer (OC) remains a lethal gynaecologic malignancy characterised by …
…A new drug to treat resistant ovarian cancer, and the first to be approved in over two decades, has been app…
…lusion Overall, prehabilitation was acceptable to patients with advanced ovarian cancer who had been referred to a multimodal prehabilitation programme…
…), colorectal (bowel), pancreatic, liver, bladder, endometrial, uterine sarcoma, ovarian and vulval, using data collected through store loyalty…
…hough more slowly for the latter. For example, BMI-attributable colorectal cancer in younger women increased from 0.9 to 1.6 per 100 000 (APC 4.3…
…g studies of populations with wide age ranges most informative. Colorectal cancer is a notable exception, with persistent increases limited to yo…